Evidence map›Paper›PMID 40830834›Full record

ArticleBMC cardiovascular disorders2025

Prognostic value of systemic immune-Inflammatory index in patients with diabetes mellitus and acute coronary syndrome after percutaneous coronary intervention: a prospective cohort study.

Leli Zhang, Shen Wang, Yue Wang, Pengrong Guo, Shou Pang, Boqun Shi, Xiaofan Wu

Abstract read
In one paragraph

Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leli ZhangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Shen WangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yue WangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pengrong GuoDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Shou PangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Boqun ShiDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaofan WuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. drwuxf@163.com.

Funding

Capital's Funds for Health Improvement and Research 2022-2-2068National Natural Science Foundations of China 82271605
6 · The paper itself

Abstract

backgroundA higher risk of cardiovascular disease has been correlated with several inflammatory biomarkers, one of which is the systemic immune-inflammatory index (SII). Nevertheless, the relationship between SII and major adverse cardiovascular and cerebrovascular events (MACCE) in patients with diabetes and acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI) remains unclear. The objective of this study was to assess the prognostic value of SII for the risk of MACCE in patients with diabetes and ACS who underwent PCI.

methodsThis study included 1782 patients with ACS and diabetes who underwent PCI successfully at Beijing Anzhen Hospital between August 2021 and April 2022, with a median follow-up of 16.2 months. According to the optimal SII cut-off value for MACCE, patients were categorized into two groups: the high SII group (SII ≥ 735.82 × 10

resultsThe incidence of MACCE was significantly higher in the high SII group than in the low SII group (11.3% vs. 6.7%, log-rank P < 0.001), indicating that among 22 patients with high SII levels, an additional MACCE event is expected to occur. Univariate Cox proportional hazards models showed that higher SII was associated with an increased incidence of MACCE (HR: 1.739, 95%CI: 1.254-2.410). After full adjustment, higher SII remained an independent risk factor for MACCE (HR: 1.540, 95%CI: 1.098-2.160) and unplanned revascularization (HR: 1.526, 95%CI: 1.011-2.301).

conclusionThis study found that elevated SII is an independent risk factor for predicting MACCE in patients with ACS and diabetes mellitus after PCI, providing a theoretical basis for postoperative anti-inflammatory therapy in this population.

Indexed as

Acute Coronary SyndromeDiabetes MellitusInflammationInflammation MediatorsPercutaneous Coronary InterventionAgedBeijingBiomarkersChinaFemaleHumansIncidenceMaleMiddle AgedPredictive Value of TestsProspective StudiesBiomarkersInflammation MediatorsAcute coronary syndromeDiabetesPercutaneous coronary interventionSystemic immune-inflammation index

Identifiers

PMID40830834
PMCPMC12362963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.